Discoveries and challenges en route to swinhoeisterol A by Duecker, Fenja L. et al.
&Natural Products
Discoveries and Challenges en Route to Swinhoeisterol A
Fenja L. Duecker,[a] Robert C. Heinze,[a] Simon Steinhauer,[b] and Philipp Heretsch*[a]
Abstract: In this work, a full account of the authors’ synthet-
ic studies is reported that culminated in the first synthesis of
13(14!8),14(8!7)diabeo-steroid swinhoeisterol A as well as
the related dankasterones A and B, 13(14!8)abeo-steroids,
and periconiastone A, a 13(14!8)abeo-4,14-cyclo-steroid. Ex-
periments are described in detail that provided further in-
sight into the mechanism of the switchable radical frame-
work reconstruction approach. By discussing failed strategies
and tactics towards swinhoeisterol A, the successful route
that also allowed an access to structurally closely related an-
alogues, such as D22-24-epi-swinhoeisterol A, is eventually
presented.
Introduction
Traditionally, the majority of bioactive compounds has been
isolated from terrestrial plants and fungi, whereas the marine
biosphere was more difficult to access. Undersea organisms
often produce structurally highly complex, rearranged secon-
dary metabolites with unique bioactivities.[1]
An increasing number of chemical syntheses relies on bioge-
netic information, gaining access to natural products via bio-
mimetic approaches.[2] Still, many of the proposed pathways
are established without the support of co-isolated biosynthetic
precursors from the producing organism. Commonly, biogenet-
ic proposals anticipate polar pathways to account for skeletal
rearrangements and radical routes are rarely considered.[3] One
class of steroidal natural products with such rearranged skele-
tons are the so-called abeo-steroids, which display one or sev-
eral C@C bond migrations with respect to the classic, tetracy-
clic steroid backbone.[4]
In recent years, our group as well as others have demon-
strated that key synthetic transformations (possibly biomimetic
in nature) can indeed be carried out using radical reactivity,
giving the desired skeletal modifications with high selectivity
as shown in the syntheses of rearranged steroids cortistatin
A,[5] aplysiasecosterol A,[6] strophasterol A,[7] pleurocin A/matsu-
takone,[8] and herbarulide.[9] It was also a cascade of rearrange-
ments initiated by an alkoxy radical that cleared the way to
the dankasterone [13(14!8)abeo-steroids][10] and the swin-
hoeisterol class of natural products [13(14!8),14(8!7)diabeo-
steroids].[11] Only recently, we achieved the synthesis of swin-
hoeisterol A (2), its 24-epi-counterpart (24-epi-2), dankastero-
ne A (3) and B (4), and periconiastone A (5),[12] the 4,14-cyclo
aldol product of the latter, starting from commercial ergosterol
(1) by exploiting a radical cascade (Scheme 1).[13] Regarding the
biological activities of these natural products, dankasterone A
(3) and B (4) show significant cytotoxicity against the P388
lymphocytic leukemia test system (ED50 2.2 and 2.8 mgmL
@1, re-
spectively)[10] whereas diabeo-steroid swinhoeisterol A (2) ex-
hibits a remarkable inhibition of the histone acetyltransferase
(h)p300 with an IC50 of 2.9 mm.
[11a] The most recently isolated
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Scheme 1. Structures of the abeo-steroids swinhoeisterol A (2), dankastero-
ne A (3) and B (4), and periconiastone A (5), their common synthetic starting
material, ergosterol (1), as well as their generic classes.




secondary metabolite, periconiastone A (5), is reported to dis-
play intriguing antibacterial activity against two Gram-positive
microbial pathogens, namely S. aureus (MIC 4 mgmL@1) and E.
faecalis (MIC 32 mgmL@1).[12]
Herein, we want to report on the evolution of our synthetic
studies towards swinhoeisterol A (2) and its 24-epi-isomer (24-
epi-2) as well as present experimental support for our mecha-
nistic proposal for our radical framework reconstruction ap-
proach.
Results and Discussion
Our rationale to gain synthetic access to the rearranged skele-
tons of abeo-steroids relied on the initial generation of an
alkoxy radical. The following radical rearrangement (Scheme 2)
enabled the synthesis of the above-mentioned natural prod-
ucts and selective access to either the mono- or diabeo-skele-
ton was gained by adapting the reaction conditions
(PhI(OAc)2/I2 for the former; HgO/I2 for the latter) to generate
B, starting from a g-hydroxy enone A. Subsequent b scission of
the C13@C14 bond in B would form an intermediary 14-oxo
functionality along with a stabilized tertiary radical at C13 (C).
An attack onto the D7-bond generates a-keto radical D, which
is either quenched reductively to give the 13(14!8)abeo skel-
eton (E)[14] as present in the dankasterone class of natural prod-
ucts, or further reacts in a Dowd–Beckwith rearrangement.[15]
This comprises of an attack of the C7-centered radical to the
14-oxo functionality to give alkoxy radical F. Another b scission,
this time of C8-C14, yields the 13(14!8),14(8!7)diabeo core
(G) of the swinhoeisterols after abstraction of an H atom (G!
H).
Initially, 5a-hydroxy enone 7 was chosen as a substrate for
the envisioned radical rearrangement (Scheme 3). As we de-
scribed in our synthesis of herbarulide,[9] the preparation of
Burawoy’s ketone (6) following reported procedures has
proven to lack reproducibility.[16] Aiming for a stepwise oxida-
tion of ergosterol (1), 6 was available in 62% yield over 4
steps.[9] Reduction with zinc in acetic acid provided 5a-enone
(not shown) in 47% along with 20% of its 5b-epimer (not
shown). While Riley oxidation employing 1,4-dioxane as solvent
gave the desired product in only low and irreproducible yields,
the solvent system pyridine/tBuOH[17] allowed for the forma-
tion of alcohol 7 in an acceptable yield of 59%. To generate
the alkoxy radical at C14 from alcohol 7, the literature-known
combination of Pb(OAc)4, I2 and CaCO3 in benzene
[18] was used
and, indeed, all isolated products showed the desired 13(14!
8),14(8!7)diabeo-skeleton, though in higher oxidation states
than expected. Diene dione 9 was obtained as the major prod-
uct (40%) along with endoperoxide 10 (20%). When the reac-
tion mixture was carefully degassed prior to addition of
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Scheme 2. Mechanistic proposal for the alkoxy radical initiated framework
reconstruction leading to the structural precursors of the dankasterones E
and swinhoeisterols H.
Scheme 3. Radical rearrangement of 7 leading to the 13(14!8),14(8!
7)diabeo structures 8, 9, and 10. ORTEP plots of 9 and 10. Thermal ellipsoids
are drawn at 50% probability. Reagents and conditions: a) Zn (29 equiv.),
HOAc, 90 8C, 3 h, 47%; b) SeO2 (4.75 equiv.), tBuOH/pyridine (4:1), 80 8C, 4 h,
59%; c) Pb(OAc)4 (2.0 equiv.), I2 (2.0 equiv.), CaCO3 (2.0 equiv.), C6H6, 85 8C,
2 h, 8 : 18%, 9 : 59%, 10 : traces. CCDC 1991055 (9) and 1991054 (10) contain
the supplementary crystallographic data (see Experimental Section).




Pb(OAc)4, 59% of 9, only traces of 10, and 18% of 15b-iodo
diene dione 8 were obtained.
To prevent formation of the oxygen adduct and to keep op-
tions for later A-ring functionalization, elimination of the terti-
ary alcohol in Burawoy’s ketone (6) was carried out using thio-
nyl chloride and basic conditions to give D4-enone 11 (75%
yield). In this case, standard Riley conditions gave D4-hydroxy
enone 12 as another substrate for the radical cascade. Again,
the Pb(OAc)4/I2-system was used leading to a different product
distribution for “open flask” and “degassed” conditions (see
Scheme 4). Tetraene dione 13 was isolated as the major prod-
uct (31% yield) and its yield could be improved to 44% when
carefully degassing the reaction mixture. Under “open flask”
conditions, 4-iodo substituted endoperoxides 16 and 17 were
obtained in 12 and 23% yield, respectively, or in 9 and 11% for
the “degassed” experiment. The formation of 16 and 17 pre-
sumably results from remaining traces of oxygen in the reac-
tion mixture. Interestingly, aerobic conditions led to the isola-
tion of 15b-iodo tetraene dione 14 (14%) whereas oxygen-free
conditions delivered the 13(14!8)abeo species 15 (13%), in-
stead, providing first confirmation of our mechanistic proposal
(Scheme 2).
Gaining synthetic access to the swinhoeisterols by further
processing one or several of the obtained products was tested
on tetraene dione 13 (Scheme 5) as well as epimeric 4-iodo en-
doperoxides 16 and 17 (Scheme 6). For 13, we envisioned to
reduce the oxo-functionality at C6 to the corresponding allylic
alcohol, which could then be used to perform a sigmatropic
rearrangement, either directly (Johnson–Claisen), after acetyla-
tion (Ireland–Claisen), or after methyl stannylation ([2,3]-
Wittig–Still), thereby installing a precursor for the exo-methyl-
ene function at C4. However, no conversion of starting material
was observed when applying Johnson–Claisen conditions to
the allylic alcohol and in case of the [2,3]-Wittig–Still rearrange-
ment, addition of nBuLi to the methyl stannylated alcohol only
resulted in the formation of the 1,2-rearranged product. In
case of the Ireland–Claisen reaction, the allylic acetate was suc-
cessfully converted to the corresponding silyl ketene acetal as
judged by 1H NMR, but further reaction to the desired carbox-
ylic acid was not successful.
Scheme 4. Radical rearrangement of 12 and product distributions depending on the reaction conditions. Reagents and conditions: a) SOCl2 (4.5 equiv.), pyri-
dine, @10 8C, 45 min, 75%; b) SeO2 (4.75 equiv.), dioxane/H2O (50:1), 65 8C, 5 h, 73%; c) Pb(OAc)4 (2.0 equiv.), I2 (1.5 equiv.), CaCO3 (2.0 equiv.), C6H6, 85 8C, 2 h,
R as in Scheme 3.
Scheme 5. Attempted sigmatropic rearrangements to introduce a synthetic
precursor for the desired exo-methylene unit.
Scheme 6. Synthetic transformations of endoperoxides 16 and 17 and
mechanistic proposal for the rearrangement to 20. Reagents and conditions:
a) PtO2 (0.2 equiv.), H2 (balloon), EtOAc, 25 8C, 4 h; b) Ag2O, THF, 25 8C, 1 h,
56% (2 steps); c) PtO2 (0.2 equiv.), H2 (balloon), EtOAc, 25 8C, 4 h, 70%;
d) Ag2O, THF, 60 8C, 16 h, 85%, R as in Scheme 3.




Since the diastereomeric endoperoxides 16 and 17 con-
tained the structural motif of a D7-9a-hydroxy ketone, which is
also present in other members of the swinhoeisterols, they
were also assumed valuable intermediates en route to 2
(Scheme 6). Thus, reduction of the peroxide functionality to
the corresponding 5,9-diol (as in 19) was carried out on both
4-iodo epimers using PtO2/H2. In case of 4b-iodo endoperoxide
16, a mixture of the diol (not shown) and epoxide 18 resulting
from concomitant SN2 reaction was obtained. Full conversion
was possible by treatment with Ag2O and gave 18 in 56%
over 2 steps. As 18 was deemed a suitable precursor for fur-
ther transformations (e.g. , Wharton transposition), diol 19 was
to be transformed to 18 as well through a SN1 reaction. Treat-
ment with Ag2O showed no conversion at room temperature
but after 16 h at 60 8C selective formation of a new product
was observed. Careful analysis of the NMR data obtained led
us to propose the structure of lactone 20, which was con-
firmed by X-ray single crystal structure analysis. Presumably,
formation of the expected cation at C4 did indeed take place
but was immediately or concertedly followed by bond migra-
tion to give 10(5!4)abeo intermediate I.
Assumedly, this oxocarbenium facilitated an attack of the C9
hydroxyl and thereby set the stage for a benzilic acid-type re-
arrangement ring contraction/expansion[19] (see structure J)
yielding lactone 20, which features immense connectivity
changes in the A and B ring. To the best of our knowledge,
this structural motif has not been observed in any steroidal
context, before. Afore mentioned Wharton transposition was
envisioned to convert epoxide 18 to C4 allylic alcohol, but as
the initial conversion to the corresponding hydrazone was un-
successful, further studies employing iodo-endoperoxides 16
and 17 were discarded.
Another compound isolated from the reaction of 12 with
Pb(OAc)4/I2 was D
4-13(14!8)abeo-steroid 15. Although not
further employed in the synthesis of the swinhoeisterols, its
isolation supported our mechanistic proposal and transforma-
tion to dankasterone A (3) in 56% yield over two steps
(Scheme 7) was successful. In the meantime, we were able to
provide proof of the cage-like 13(14!8)abeo-4,14-cyclo struc-
ture of periconiastone A (5)[12] by X-ray single crystal analysis.
Previously, we had synthesized 5 from dankasterone B (4)[13]
and now set out to explore the possibility to generate an eno-
late by 1,4-reduction of dankasterone A (3), which would then
undergo aldol addition and give the desired 4,14-cyclo skele-
ton. Interestingly, reaction with L-selectride only gave 3a-alco-
hol 21, the product of 1,2-reduction, presumably due to steric
inaccessibility of C5.
As so far, all our efforts to process any rearranged material
obtained towards swinhoeisterol, and for a further generaliza-
tion of the radical cascade, next g-hydroxy enone 22 which
was accessible in 4 steps and 42% from ergosterol (1)[7] was to
be investigated. When treating 22 with Pb(OAc)4/I2, four main
products were obtained after careful separation (Scheme 8A).
Once more, two of those contained the diabeo-structure
(triene dione 25 and its 15b-iodo analogue 26) ; the other two
being 13(14!8)abeo dione 23 and its 7a-iodo analogue 24. To
further substantiate our mechanistic proposal, 23 as well as 24
were both separately treated with Pb(OAc)4/I2. As expected, no
conversion of the starting material was observed in case of
Scheme 8. A : Radical rearrangement of 22 leading to mono- and diabeo
structures 23, 24, 25 and 26. B and C : Attempted rearrangements using al-
ternative conditions. Reagents and conditions a) Pb(OAc)4 (2.0 equiv.), I2
(2.0 equiv.), CaCO3 (2.0 equiv.), C6H6, 85 8C, 2 h; b) HgO (2.7 equiv.), I2
(2.4 equiv.), C6H6, 105 8C (sealed tube), 2 h, 68%; c) PhI(OAc)2 (2.0 equiv.), I2
(1.0 equiv.), C6H6, 25 8C, 30 min, 76%; d) Ag2O (2.0 equiv.), I2 (1.5 equiv.), C6H6,
85 8C, 2 h, 27: 37% (5a/5b 2.3:1), 28 : 19%; e) [Ir(dF(CF3)ppy)2(5,5’-
d(CF3)bpy)]PF6 (3 mol%), (nBu4)NO2CCF3 (0.4 equiv.), blue LEDs, PhMe, 35 8C,
3 d, 17% (40% brsm). brsm=based on recovered starting material, R as is
Scheme 3.
Scheme 7. Synthesis of periconiastone A (5) (ORTEP plot of 5. Thermal ellip-
soids are drawn at 50% probability) and alternative synthetic access to dan-
kasterone A (3) and its reduction. Reagents and conditions: a) DBU
(10 equiv.), PhMe, 25 8C, 12 h; b) K2CO3 (5.0 equiv.), MeOH, 25 8C, 1 h; c) DMP
(2.0 equiv.), CH2Cl2, 25 8C, 1 h, 56% (2 steps) ; d) L-selectride (2.0 equiv.), THF,
@78 8C, 1 h, 87%. DBU=1,8-diazabicyclo[5.4.0]undec-7-ene DMP=Dess–
Martin periodinane, R as in Scheme 3. CCDC 1989984 contains the supple-
mentary crystallographic data for compound 5 (see Experimental Section).




dione 23, but the reaction of iodide 24 gave rise to 63% of
diabeo-compound 25. As we reported earlier, it was possible
to selectively access either the diabeo-framework (25, HgO/I2,
68% yield) or the monoabeo-skeleton (24, PhI(OAc)2, 76%
yield), depending on the conditions to generate the initial
alkoxy radical.[13] To test if the rearrangement to the diabeo-
structures could be initiated without employing toxic Hg or Pb
reagents, 22 was treated with Ag2O and I2.
[20] However, only
elimination of the 14-hydroxyl was observed (to give 28) along
with partial i-steroid opening to give iodide 27 as a mixture of
epimers (5a/5b 2.3:1).[21] Knowles’ photocatalytic ring expan-
sion conditions[22] either did not yield any rearranged product
but resulted in the isolation of D8, 14-steroid 29.[14a] Any other
attempts to initiate a radical-promoted cascade employing
other metal salts, did not lead to any conversion of the starting
material.
To further study the influence of the stereoconfiguration at
C14 on the radical cascade, we prepared14b-hydroxy enone 34
(Scheme 9). Since all Riley oxidations carried out resulted in
14a-hydroxylation, a Schenck ene reaction followed by reduc-
tion of the hydroperoxide was envisioned, instead. i-Steroid
enone 30 was converted into TMS dienol ether 31, which was
then treated with oxygen and TPP as photosensitizer under ir-
radiation with white light to give 14a-hydroperoxide 32 and
14b-hydroperoxide 33 (56 and 12% yield, respectively). While
14a-OOH 32 could be converted to 13(14!8)abeo-dione 23 in
a yield of 38% using Danieli’s conditions (FeSO4),
[14b] 14b-OOH
33 was reduced to the corresponding alcohol 34, which was
then exposed to Pb(OAc)4/I2. This time, no rearrangement of
the steroid skeleton was observed. The alkoxy radical generat-
ed at C14 rather added to the double bond at C8, giving rise
to an epoxide and the C7 centered radical was then quenched
by iodine leading to 7a-iodo epoxide 35. This difference in re-
activity can be explained with an unfavorable orbital overlap
of the radical SOMO and the s-orbital of the C13@C14 bond so
that no b scission could occur.
As the radical rearrangement was most selective on the i-
steroid system, it was chosen as starting material for our syn-
thetic efforts towards swinhoeisterol A (2) and analogues. In
the following, we want to discuss the major synthetic challeng-
es that had to be overcome en route to swinhoeisterol A
(Scheme 10). Starting from ergosterol (1), our synthetic ap-
proach consisted of an oxidative cleavage/olefination/hydroge-
nation sequence of D22 to introduce the desired (saturated)
campestane side chain (Scheme 10, A). We envisioned to intro-
duce the exo-methylene moiety via elimination of a hydroxy-
methyl group at C4 at a late stage of the synthesis making use
of an enone functionality in the A-ring (Scheme 10, B). This key
intermediate was traced back to a diene dione system from
our radical cascade (Scheme 10, C).
Following these studies, we attempted a synthetic approach
towards swinhoeisterol A (2) making use of 25 (Scheme 11),
which was obtained in a good yield from 22 when applying
HgO/I2 (68%). It was possible to differentiate the C6- and C14-
oxo functionalities of diene dione 25 by selective formation of
C14 silyl enol ether 36. We planned to adjust the oxidation
state by 1,6-reduction with L-selectride, which along with the
expected reduction involved the incorporation of an oxygen at
C9 to give 9a-hydroxy dione 37 presumably through attack of
O2 by the intermediary dienolate. Even though this was not
the expected product, the synthetic route was continued,
since the obtained 9a-hydroxy enone pattern is present in
swinhoeisterol B (not shown). Reduction with LiAlH4 gave de-si-
lylated 6a-OH 38, which seemed to be a suitable precursor for
Scheme 9. Synthetic access to 14b-OH 34 and attempted rerarrangement.
Reagents and conditions: a) TMSOTf (1.5 equiv.), Et3N (2.0 equiv.), CH2Cl2,
0 8C, 1 h; b) TPP (0.2 mol%), O2, hn, CH2Cl2, @78 8C, 15 min, 32 : 56%, 33 :
12%; c) FeSO4·7H2O (1.05 equiv.), acetic buffer (pH 3), THF/H2O (1.5:1), 25 8C,
1 h, 38%; d) PPh3 (1.0 equiv.), CH2Cl2, 25 8C, 1 h, 71%; e) Pb(OAc)4 (2.0 equiv.),
I2 (2.0 equiv.), CaCO3 (2.0 equiv.), C6H6, 85 8C, 1 h, 42%. TMSOTf= trimethylsil-
yl trifluoromethanesulfonate, TPP=meso-tetraphenylporphyrin, R as in
Scheme 3.
Scheme 10. Analysis of synthetic challenges in swinhoeisterol A (2).




an i-steroid opening. However, when treating 38 with acetic
acid and BF3·OEt2,
[23] unexpected anthrasteroid[24a,b] 39 was iso-
lated in 87%. Presumably, the initial i-steroid opening took
place as expected (K) but was followed by generation of
cation L through loss of the hydroxy group. Stabilization of the
cation by bond migration could then lead to spiro-compound
M,[24c,d] which, after formation of the C1@C6 bond, gives Whe-
land complex N. Loss of a proton would generate aromatic 39,
whose 1(10!6)abeo-structure can be found in a number of
natural products.[24d-g]
Through these experiments, the tertiary alcohol at C9 had
been identified to be problematic in the cyclopropane opening
reaction of 38 and, thus, its formation was tried to be avoided
by vigorous exclusion of oxygen prior to reduction with L-se-
lectride (Scheme 12). The so-generated D8-ene dione system
tautomerized (Scheme 10, C), leading to a tedious isolation ac-
companied by decomposition. To prevent this problem, we de-
cided to add another reducing reagent to the reaction mixture
to convert one or both ketones to the corresponding alcohols.
Interestingly, the initially formed lithium enolate protected the
respective ketone against reduction with lithium aluminum hy-
dride, and only the 6-oxo moiety was reduced to give b-hy-
droxy ketone 40. Its treatment with BF3·OEt2 and acetic acid
again resulted in an undesired side reaction, i.e. , isomerization
of D8 into conjugation with the ketone to give D5,7-diene 41 as
the major product (51%) and only minor quantities (12%) of
the desired D5,8-diene 42. Saponification (K2CO3, MeOH)
proved to be difficult on 42, and de-acetylation could only be
achieved under reductive conditions (DIBAl-H) leading to con-
comitant reduction of the 14-oxo functionality to furnish 43.
To instead employ D5,7-diene 41, several approaches were in-
vestigated, but isomerization of one or both of the two double
bonds proved to be impossible. We suspected that isomeriza-
tion of D8 had occurred due to activation of the ketone with
BF3·OEt2, and, thus, reduced 40 to 6,14-diol 44. Fortunately,
this time no isomerization was observed during i-steroid open-
ing and subsequent de-acetylation (DIBAl-H) gave 3,14-diol 43
in a convincing yield of 74% over 2 steps. Employing Oppen-
auer conditions to achieve oxidation and isomerization to
enone 45 did not lead to any conversion. Hence, a stepwise
process using Dess–Martin periodinane and then DBU estab-
lished key-intermediate 45 with a yield of 79% over 2 steps.
As a handle to construct the requisite exo-methylene group
along with the necessary trans ring junction of the A and B
ring (Scheme 10, B), we envisioned the installation of a
hydroxymethyl group at C4 and elimination of the primary al-
cohol to furnish the methylene unit. Initially, we intended to
install the remaining carbon atom through a reductive alkyla-
tion protocol under dissolving metal conditions. As the direct
addition of gaseous formaldehyde did not yield any of the de-
sired hydroxy methylated product,[25] the trapping as a silyl
enol ether was investigated. We applied a procedure described
by Mueller and Gillick,[26] which involved the generation of so-
called lithium bronze.[26c] Thus, enone 45 was readily converted
into silyl enol ether 46 (Scheme 13). To introduce a suitable
methylene precursor, a variety of conditions to alkylate 46
were tested. Methods using aqueous formaldehyde either in
Scheme 11. Transformations on i-steroid diene dione 25 and mechanistic
proposal for the formation of anthrasteroid 39. Reagents and conditions:
a) TESOTf (5.0 equiv.), 2,6-lutidine (10 equiv.), CH2Cl2, 0 8C, 1 h, 86%; b) L-se-
lectride (3.0 equiv.), THF, @78 8C, 1 h, 53%; c) LiAlH4 (5.0 equiv.). THF, 0 8C,
1 h, 40%; d) BF3·OEt2/HOAc/Et2O (1:1:2), 0 8C, 1 h, 87%. TESOTf= triethylsilyl
trifluoromethanesulfonate, R as in Scheme 3.
Scheme 12. i-Steroid opening and synthesis of key fragment 45. Reagents
and conditions: a) L-selectride (1.5 equiv.), LiAlH4 (2.5 equiv.), THF, @78 to
0 8C, 2 h, 55%; b) BF3·OEt2/HOAc/Et2O (1:1:2), 0 8C, 45 min, 41: 51%, 42 : 12%;
c) DIBAl-H, THF, @78 8C, 1.5 h, 76%; d) NaBH4 (2.5 equiv.), CeCl3·7H2O
(2.5 equiv.), MeOH/CH2Cl2 (2:1), @10 8C, 30 min, 87%; e) BF3·OEt2/HOAc/Et2O
(1:1:2), 0 to 25 8C, 5 h, 88%; f) DIBAl-H, THF, @78 8C, 1.5 h, 89%; g) DMP,
NaHCO3, CH2Cl2, 25 8C, 1 h, 82%; h) DBU, CH2Cl2, 25 8C, 1 h, 91%. DIBAl-
H=diisobutylaluminum hydride, R as in Scheme 3.




combination with Lewis acids such as Sc(OTf)3
[27] or Yb(OTf)3
[28]
or by addition of a de-silylating reagent (e.g. , TBAF[29]) have
been described. Even though addition of formaldehyde could
be detected by mass spectrometry, the isolation of the desired
g-hydroxy ketone was unsuccessful and instead, ketone 47
was obtained, the product of a retro-aldol reaction.[30] To cir-
cumvent this problem, we attempted to install a protected hy-
droxy methyl moiety. However, when treating silyl enol ether
46 with BOMCl and varying Lewis acids,[31] only a-halogenated
ketones were isolated, yielding 4-chloro- and 4-fluoro-ketones
when using SnCl4, TiCl4, or BF3·OEt2, respectively. Consequently,
the introduction of other functional groups known to be con-
vertible into a methylene group was considered. Thus, treat-
ment of silyl enol ether 46 with ethyl bromo acetate to give
the corresponding ethyl ester[26b] or Eschenmoser’s salt to give
the dimethylamine,[32] were attempted but did not yield any
desired product other than ketone 47.
Alternatively, the method by Nishiyama and Stork[33] was
considered and successfully executed to introduce the C4 hy-
droxymethyl moiety. Thus, enone 45 was selectively reduced
under Luche conditions to the corresponding allylic alcohol,
which was then treated with chloro(bromomethyl)dimethylsi-
lane and triethyl amine to give the crucial precursor for a radi-
cal cyclization. Initial results employing the (bromomethyl)silyl
ether (not shown) in the radical cyclization and subsequent
Tamao oxidation[34] lacked reproducibility. An alternative proce-
dure employing substoichiometric amounts of the tin reagent
required the corresponding (iodomethyl)silyl ether 48.[35]
Hence, allylic alcohol was converted to the (chloromethyl)silyl
ether (not shown) followed by Finkelstein reaction to give
iodide 48. Radical cyclization was then achieved by treatment
with catalytic quantities of AIBN and nBu3SnCl and stoichio-
metric amounts of NaBH3CN to result in the formation of a ox-
asilolane (not shown), which, upon oxidative work up (H2O2,
KF), delivered diol 49 in 36% yield along with 16% of its unde-
sired 5b-epimer. Finally, the primary alcohol was converted to
the corresponding triflate with Tf2O at @78 8C, which, upon
warming to 25 8C, eliminated to yield the desired exo-methyl-
ene group in D22-24-epi-swinhoeisterol A D22-24-epi-2.[37]
With a reliable route for swinhoeisterol A’s tetracyclic core,
one last synthetic challenge had to be overcome, i.e. , the in-
troduction of the correctly configurated side chain (Scheme 10,
A). It was deemed strategically advantageous, to perform the
necessary modifications at a late stage. Since we envisioned a
sequence of oxidative C@C bond cleavage, olefination, and hy-
drogenation, many synthetic intermediates bearing easily ac-
cessible double bonds additional to D22 had to be excluded a
priori. Thus, hydroxymethylated 49 and enone 45 presented
themselves as promising candidates (Scheme 14). Oxidative D22
bond cleavage on the stage of diol 49 was achieved through
ozonolysis and reductive workup. Attempted Julia–Kocienski
olefination proved unsuccessful due to low solubility of the
starting material. Thus, the 1,3-diol functionality of 49 was pro-
tected as an acetonide, which was processed to the corre-
sponding aldehyde. Again, no conversion of the starting mate-
rial in an attempted Julia–Kocienski reaction could be ob-
served. We, thus, shifted our attempts towards enone 45. Ozo-
nolysis gave aldehyde 50, and this time, Julia–Kocienski olefi-
nation using sulfone 51 indeed led to conversion of starting
material. Unfortunately, not the desired olefin, but tetrazole 52,
which presumably arose from aldol reaction between enoliza-
ble C7 and the 22-oxo functionality followed by trapping of
the alcoholate by the tetrazole moiety of sulfone 51, was iso-
lated. As a consequence of this reactivity, i-steroid diol 44, an
intermediate without the oxo moiety at C14, was anticipated
to adopt a less reactive conformation and, thus, seemed to be
a better choice. However, treatment of the corresponding alde-
hyde of diol 44 with LiHMDS and sulfone 51 only led to isola-
tion of material with the C6 hydroxyl bearing a tetrazole sub-
stituent. One of the few remaining intermediates to conduct
the ozonolysis/olefination approach was b-hydroxy ketone 40,
which, after conversion to aldehyde 53 eventually afforded the
desired olefin 55 (with the double bond being Z configurated)
along with small quantities of aldol product 54. Fortunately, it
was possible to almost suppress formation of 54 (less than
5%) when increasing the amount of sulfone 51 (5.0 equiv.).
Scheme 13. Attempted reductive alkylation of enone 45, successful conver-
sion to hydroxymethylated 49 by Nishiyama–Stork reaction and elimination
of the primary alcohol to D22-24-epi-2. Reactions and conditions: Li·4 NH3,
@78 to 25 8C; then 45, THF, @78 8C, 30 min; then TMSCl/Et3N (1:2), @60 to
@20 8C, 1 h; b) NaBH4 (0.6 equiv.), CeCl3·7H2O (1.5 equiv.), MeOH, @10 8C,
20 min; c) (chloromethyl)-chlorodimethylsilane (5.0 equiv.), Et3N (10 equiv.),
DMAP (0.2 equiv.), CH2Cl2, 25 8C, 1 h; d) NaI (50 equiv.), acetone, 60 8C, 16 h,
83% (3 steps) ; e) nBu3SnCl (0.2 equiv.), NaBH3CN (2.0 equiv.), AIBN
(0.1 equiv.), tBuOH, 85 8C, 16 h; then KF (10 equiv.), KHCO3 (10 equiv.), H2O2/
MeOH/THF (2:2:1), 25 8C, 30 min, 36%; f) Tf2O (2.5 equiv.), 2,6-di-tert-butyl-4-
methylpyridine (7.5 equiv.), CH2Cl2, @78 8C, 5 min; then MeOH (30 equiv.),
DBU (20 equiv.), @78 to 25 8C, 2 h, 62%. TMS= trimethylsilyl, DMAP=4-(di-
methylamino)pyridine, AIBN=2,2’-azobis(isobutyronitrile), Tf= trifluorome-
thanesulfonyl, R as in Scheme 3.




That way, olefin 55 was obtained in 86% yield. To furnish the
desired saturated campestane side chain, hydrogenation con-
ditions were tested on olefin 55, but no conversion of starting
material was observed under the conditions employed. Further
reduction experiments were then carried out on diol 56, which
was obtained by reduction with NaBH4.
Hydrogenation of a 22Z double bond is known to be more
difficult than of the corresponding 22E isomer.[37] In agreement,
in most experiments no conversion was achieved (Table 1, en-
tries 3–9) and only elevated hydrogen pressure (40–60 bar) led
to complete conversion to 57. Unfortunately, varying degrees
of epimerization at C24 occurred during the course of this re-
action[38] yielding up to 50% of the undesired ergostane prod-
uct when using Pd/C (entry 1) and still 25% when Pt/C was
used (entry 2). Attempted alternatives, such as Wilkinson’s
(entry 6) or Crabtree’s catalyst (entry 7) as well as Shenvi’s radi-
cal hydrogenation method (entries 8 and 9)[39] did not lead to
any conversion of starting material.
As hydrogenation of a 22E-configurated double bond with-
out epimerization of C24 was deemed more promising, we car-
ried out several isomerization experiments to convert 22Z to
22E, but could eventually not succeed in identifying a viable
method. At this point, we turned our attention to rather func-
tionalize the side chain double bond and remove the thus-in-
stalled functional group reductively in a separate step. Intro-
duction of sulfur-containing functionalities failed and halogen-
ation with bromine to the dibromide and subsequent treat-
ment with AIBN/nBu3SnH only led to a mixture of 22E- and
22Z-diol 56. To our delight, hydroboration and subsequent oxi-
dation with NaOH/H2O2 afforded primarily a 6,14,23-triol (not
shown) under concomitant reduction of C14. Acetonide forma-
tion of the thus-obtained 1,3-diol unit and functionalization of
the side chain alcohol (predominantly 23-OH) to a xanthate,
followed by Barton-McCombie deoxygenation eventually gave
the desired saturated campestane side chain without any epi-
merization (Scheme 15).
All synthetic challenges were thus coped with so that rather
similar approaches led to the synthesis of natural swinhoeister-
ol A (2, b-series) and 24-epi-swinhoeisterol A (24-epi-2, a-series).
As it was initially uncertain at which stage an installation of
the correct side chain fragment would be feasible, the synthet-
ic route had also been carried out in the ergostane series,
starting from ergosterol (1) without hydrogenation of the D22
bond. This route enabled access to D22-24-epi-swinhoeisterol A
(D22-24-epi-2) in 16 steps and a total yield of 1.5%.
In summary, access to the diabeo-skeleton (25 and 25a) via
g-hydroxy enones 22 or 22a was accomplished in five to six
steps, respectively, starting from ergosterol (1). b-Hydroxy ke-
tones 40 and 40a, obtained after reduction, were further pro-
cessed following two different pathways. For the synthesis of
swinhoeisterol A (2), 40a was subjected to ozonolysis and
Julia–Kocienski olefination to give 55b, followed by a hydrobo-
ration, oxidation/Barton–McCombie deoxygenation sequence
to yield the desired saturated campestane side chain as in
58b. Opening of the i-steroid moiety led to acetate 59b. 40
and 40a, on the other hand, were reduced to diols 44 and
44a and subsequent treatment with BF3·OEt2 under acidic con-
ditions gave the corresponding acetates 59 and 59a. De-acety-
lation was accomplished using DIBAl-H giving rise to 43, 43a,
and 43b. Oxidation with DMP and subsequent isomerization
Scheme 14. Attempts to install the necessary campestane side chain. Re-
agents and conditions: a) O3, CH2Cl2/pyridine (99:1), @78 8C, 3 min; then
PPh3 (1.1 equiv), @78 to 25 8C, 16 h, 92%; b) 51 (5.0 equiv.), LiHMDS
(5.0 equiv.), THF, @78 to 25 8C, 22 h, 52%; c) O3, CH2Cl2/pyridine (99:1),
@78 8C, 45 min; then PPh3 (2.0 equiv.), @78 to 25 8C, 16 h, 73%; d) 51
(5.0 equiv), LiHMDS (3.1 equiv), THF, @78 to @65 8C, 2 h, 86%; e) NaBH4
(2.5 equiv), CH2Cl2/MeOH (1:1), @10 8C, 30 min, 94%. HMDS=1,1,1,3,3,3-hex-
amethyldisilazide, R as in Scheme 3.
Table 1. Attempted hydrogenation of D22 in 56.
Entry Catalyst Pressure H2 [bar] Epimerization at C24
[a] Conversion
1 Pd/C 40 &50% complete
2 Pt/C 40 &25% complete
3 PtO2 60 – none
4 Ir 60 – none
5 Rh/C 60 – none
6 [RhCl(PPh3)3] 60 – none





[a] Ratio of epimers determined from 13C NMR spectra (see Supporting In-
formation of Ref. [13]). [b] Crabtree catalyst : (SP-4)tris(cyclohexyl)phos-
phane[(1–2-h :5–6-h)-cycloocta-1,5-diene]pyridineiridium hexafluorophos-
phate. [c] 4.0 equiv. of PhSiH3 ; acac=acetylacetonate, dpm=2,2,6,6-tetra-
methyl-3,5-heptanedionato.




Scheme 15. Overview of the synthetic routes to swinhoeisterol A (2, b series), 24-epi-swinhoeisterol A (24-epi-2, a series) and D22-24-epi-swinhoeisterol A (D22-
24-epi-2) starting from ergosterol (1). Reactions and conditions: a) PtO2 (0.1 equiv.), H2 (20 bar), EtOAc, 25 8C, 24 h, 22a : 88%; b) HgO (2.7 equiv.), I2 (2.4 equiv.),
C6H6, 105 8C, 2 h, 25 : 68%, 25a : 68%; c) L-selectride (2.0 equiv.), THF, @78 8C, 1 h; then LiAlH4 (2.0 equiv.), @78 to 0 8C, 1 h, 40 : 55%, 40a : 54%; d) O3, CH2Cl2/
pyridine (99:1), @78 8C, 45 min; then PPh3 (2.0 equiv.), @78 to 25 8C, 16 h; e) 51 (5.0 equiv.), LiHMDS (3.1 equiv.), THF, @65 8C, 1 h; then 40, @65 8C, 1 h, 55b :
63% (2 steps); f) BH3·THF (10 equiv.), THF, 0 to 25 8C, 16 h; then NaOH/H2O2 (1:1), 25 8C, 1 h; g) CSA (1.2 equiv.), (MeO)2CMe2/CH2Cl2 (1:5), 0 8C, 1 h; h) KHMDS
(2.0 equiv.), CS2 (5.0 equiv.), THF, @78 to 25 8C, 1.5 h; then MeI (7.5 equiv.), 25 8C, 45 min; i) AIBN (0.5 equiv.), nBu3SnH (5.0 equiv.), C6H6, 85 8C, 3 h, 58b : 54%
(4 steps); j) BF3·OEt2/HOAc/Et2O (1:1:2), 0 to 25 8C, 5 h, 59b : 82%; k) DIBAl-H, THF, @78 8C, 1 h, 43 : 89%, 43a : 86% 43b : 83%; l) DMP (3.0 equiv.), NaHCO3
(6.6 equiv.), CH2Cl2, 25 8C, 1 h; m) DBU (0.2 equiv.), CH2Cl2, 25 8C, 1 h, 45 : 75% (2 steps), 45a : 79% (2 steps), 45b : 73% (2 steps) ; n) NaBH4 (0.6 equiv.),
CeCl3·7H2O (2.5 equiv.), MeOH, @10 8C, 20 min; o) chloro(chloromethyl)dimethylsilane (5.0 equiv.), Et3N (10 equiv.), DMAP (0.2 equiv.), CH2Cl2, 25 8C, 1 h, 60 :
83% (2 steps), 60b : 71% (2 steps); p) NaI (50 equiv.), acetone, 60 8C, 16 h; q) nBu3SnCl (0.2 equiv.), NaBH3CN (2.0 equiv.), AIBN (0.1 equiv.), tBuOH, 85 8C, 16 h;
then KF (10 equiv.), KHCO3 (10 equiv.), H2O2/MeOH/THF (2:2:1), 25 8C, 30 min, 49 : 36% (2 steps), 49b : 39% (2 steps) ; r) Tf2O (2.5 equiv.), 2,6-di-tbutyl-4-methyl-
pyridine (7.5 equiv.), CH2Cl2, @78 8C, 5 min; then MeOH (30 equiv.), DBU (20 equiv.), @78 to 25 8C, 2 h, D22-24-epi-2 : 62%, 2 : 73%; s) NaBH4 (2.5 equiv.),
CeCl3·7H2O (2.5 equiv.), MeOH, @10 8C, 30 min, 44 : 86%, 44a : 87%; t) BF3·OEt2/HOAc/Et2O (1:1:2), 0 to 25 8C, 5 h, 59 : 88% 59a : 86%; u) NaBH4 (0.6 equiv.),
CeCl3·7H2O (2.5 equiv.), MeOH, @10 8C, 20 min; v) (bromomethyl)chlorodimethylsilane (15 equiv.), Et3N (20 equiv.), DMAP (0.2 equiv.), CH2Cl2, 25 8C, 1 h, 61a :
78% (2 steps) ; w) AIBN (1.0 equiv.), nBu3SnH (5.0 equiv.), C6H6, 85 8C, 16 h; then KF (10 equiv.), KHCO3 (10 equiv.), H2O2/MeOH/THF (2:2:1), 25 8C, 2.5 h, 49a : 15–
34%; x) Tf2O (10 equiv.), 2,6-lutidine (15 equiv.), CH2Cl2, @78 8C, 10 min; then MeOH (10 equiv.), DBU (20 equiv.), @78 to 25 8C, 1.5 h, 24-epi-2 : 72%. CSA=cam-
phorsulfonic acid, py=pyridine, PT=1-phenyl-1H-tetrazol-5-yl.




of the D5 bond with DBU yielded enones 45, 45a, and 45b.
Luche reduction and silylation with (chloromethyl)- or (bromo-
methyl)chlorodimethylsilane gave (chloromethyl)silyl ethers 60
and 60b, and (bromomethyl)silyl ether 61a, respectively. As
classic Nishiyama-Stork conditions (61a, AIBN, nBuSnH) fol-
lowed by Tamao oxidation gave crucial diol 49a only in low
and varying yields (15–34%), we adjusted the synthetic route
towards D22-24-epi-2 and 2. (Chloromethyl)silyl ethers 60 and
60b were transformed to the corresponding (iodomethyl)silyl
ethers using Finkelstein conditions and then treated with cata-
lytic amounts of AIBN and nBu3SnCl and a stoichiometric
amount of NaBH3CN prior to oxidation, facilitating a reliable
access to diols 49 and 49b. Finally, triflation of the primary al-
cohol and subsequent elimination afforded 2, 24-epi-2, and
D22-24-epi-2, respectively, bearing the characteristic exo-methyl-
ene group of the swinhoeisterols.
Conclusion
We herein detailed our efforts towards the synthesis of swin-
hoeisterol A (2) and discussed major challenges that were
overcome during the development of a viable synthetic route.
Additionally, the synthesis of the first analogue, D22-24-epi-
swinhoeisterol A (D22-24-epi-2) was outlined as well as several
experiments that were carried out to support our mechanistic
proposal for the radical framework reconstruction. Two unex-
pected rearrangements of the steroid skeleton were observed,
one of them leading to hydroxy lactone 20, which had not
been reported before. The synthesis of the remaining mem-
bers of the swinhoeisterol class and the biological evaluation
of all synthesized natural products are ongoing in our labora-
tory.
Experimental Section
Crystallographic data : Deposition numbers 1989984 (5), 1991055
(9), and 1991054 (10) contain the supplementary crystallographic
data for this paper. These data are provided free of charge by the
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tionszentrum Karlsruhe Access Structures service.
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